New injection could ease pain after belly surgery
NCT ID NCT07491146
First seen Jun 27, 2026 · Last updated Jul 22, 2026 · Updated 2 times
Summary
This study tests a new drug called HSK55718 for pain after abdominal surgery. About 200 adults will receive either the drug, a placebo, or an active comparator. The goal is to see if it reduces pain over 24 hours and to check its safety.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- HSK55718 injection
- What this could lead to
- If successful, this could provide a new painkiller option for people recovering from abdominal surgery, potentially with fewer side effects than current treatments.
- What could go wrong
- This is an early Phase 2 trial with only 200 participants. It may not show clear benefit or could have unexpected side effects. Results may not apply to all types of surgery.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PAIN AFTER ABDOMINAL SURGERY are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sichuan Provincial People's Hospital
RECRUITINGChengdu, Sichuan, China
-
The Third Xiangya Hospital of Central South University, Changsha, hunan
RECRUITINGChangsha, Hunan, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.